The course of non-melanoma skin cancer
There are two main types of non-melanoma skin cancer, known as basal cell carcinoma and squamous cell carcinoma. Basal cell carcinoma is the most common kind of skin cancer, but it usually grows slowly. Squamous cell carcinoma is somewhat more aggressive. Most of these tumors are discovered before they spread to other parts of the body, though.
Basal cell carcinoma
Basal cell carcinoma (basal cell cancer) mainly affects people over the age of 60 and is most commonly found on the face, neck or other parts of the head that are regularly exposed to sunlight. It usually grows slowly and stays in the area where it first developed. So it's generally discovered at a stage where it can still be completely removed during surgery. But it's not totally harmless: If it's only treated very late, or not treated at all, it can enter deeper layers of tissue. This can cause damage to things like your nose, eyes and facial bones.
Because basal cell carcinoma rarely spreads to other parts of the body (metastasis), it is rarely fatal. Only about 1 out of 1,000 people who have basal cell cancer die of it.
Squamous cell carcinoma
Squamous cell carcinoma is also most common in older people. The average age of those who have this disease is 70. It nearly always develops on parts of the body that are exposed to the sun, especially on the face, ears, lower lip and the back of your hands.
Like basal cell carcinoma, squamous cell carcinoma grows where it first developed, damaging nearby tissue. But it is more aggressive than basal cell carcinoma, particularly if it grows in an old scar, a sore, or on your lips or ears.
If left untreated, there is a danger that the cancer might spread to other parts of the body. Squamous cell carcinoma is usually detected before it spreads, though. Then it is usually quite easy to treat. About 40 to 50 out of 1,000 people with squamous cell carcinoma die of it.
People who have had skin cancer in the past are more likely to get skin cancer in the future. If it comes back, it may be more aggressive than it was the first time.
Pre-cancerous conditions: Actinic keratosis and Bowen’s disease
Squamous cell carcinoma usually develops from abnormal cells due to skin conditions such as actinic keratosis or Bowen’s disease. These conditions are treated in order to prevent cancer from developing.
Actinic keratosis (also called solar keratosis or senile keratosis) arises if skin is constantly exposed to the sun, becoming thicker and harder as a result. It typically affects older people who live in regions with strong sunlight. Actinic keratosis generally appears on several areas of skin. The affected skin is reddish or brown in color, rough and scaly, and sometimes thicker than normal skin. It may have “pointy” bumps on it.
It is very difficult to say whether actinic keratosis will go away or develop into cancer. Doctors generally suggest having treatment to remove the abnormal tissue.
Bowen’s disease (intra-epidermal squamous cell carcinoma) is characterized by a clearly defined reddish, scaly patch of skin. It develops into squamous cell carcinoma in about 3 out of 100 people. This kind of tumor is fairly aggressive and often spreads to other parts of the body.
Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Deutsche Krebsgesellschaft (DKG), Deutsche Krebshilfe (DKH). S3-Leitlinie zur Diagnostik, Therapie und Nachsorge des Melanoms. AWMF-Registernr.: 032-024OL. July 2018. (Leitlinienprogramm Onkologie).
Bath-Hextall FJ, Matin RN, Wilkinson D, Leonardi-Bee J. Interventions for cutaneous Bowen's disease. Cochrane Database Syst Rev 2013; (6): CD007281.
Baxter JM, Patel AN, Varma S. Facial basal cell carcinoma. BMJ 2012; 345: e5342.
Dellavalle R. Skin cancer, moles, and actinic keratosis. In: Williams H, Bigby M, Herxheimer A, Naldi L, Rzany B, Dellavalle R (Ed). Edvidence-based dermatology. London: BMJ Books; 2014. S. 223-319.
Deutsche Krebsgesellschaft (DKG), Deutsche Dermatologische Gesellschaft (DDG). Aktinische Keratose und Plattenepithelkarzinom der Haut (S3-Leitlinie). AWMF-Registernr.: 032-022. June 2019.
Gemeinsamer Bundesausschuss (G-BA). Hautkrebsscreening. Zusammenfassende Dokumentation des Unterausschusses „Prävention“ des Gemeinsamen Bundesausschusses. March 31, 2008.
Robert Koch-Institut (RKI), Gesellschaft der epidemiologischen Krebsregister in Deutschland (GEKID). Krebs in Deutschland für 2013/2014. 2017.
Roewert-Huber J, Stockfleth E, Kerl H. Pathology and pathobiology of actinic (solar) keratosis - an update. Br J Dermatol 2007; 157 Suppl 2: 18-20.
Werner RN, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A. The natural history of actinic keratosis: a systematic review. Br J Dermat 2013; 169(3): 502-518.
IQWiG health information is written with the aim of helping
people understand the advantages and disadvantages of the main treatment options and health
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.